Education
About Us
Working with TipRanks
Follow Us
Easton Pharmaceuticals (EAPH)
:EAPH
EAPH Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume800.00
Average Volume (3M)251.97K
Market Cap
$933.00
Enterprise ValueN/A
Total Cash (Recent Filing)$23.19B
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta42.65
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding932,729,000
10 Day Avg. Volume8,400
30 Day Avg. Volume251,973
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.44
Price to Cash Flow (P/CF)31.00
P/FCF Ratio16.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
EAPH FAQ
What was Easton Pharmaceuticals’s price range in the past 12 months?
Currently, no data Available
What is Easton Pharmaceuticals’s market cap?
Easton Pharmaceuticals’s market cap is $933.00.
When is Easton Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Easton Pharmaceuticals’s earnings last quarter?
Easton Pharmaceuticals released its earnings results on Jun 13, 2019. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
Is Easton Pharmaceuticals overvalued?
According to Wall Street analysts Easton Pharmaceuticals’s price is currently Overvalued.
Does Easton Pharmaceuticals pay dividends?
Easton Pharmaceuticals does not currently pay dividends.
What is Easton Pharmaceuticals’s EPS estimate?
Easton Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Easton Pharmaceuticals have?
Easton Pharmaceuticals has 932,729,000 shares outstanding.
What happened to Easton Pharmaceuticals’s price movement after its last earnings report?
Easton Pharmaceuticals reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Easton Pharmaceuticals?
Currently, no hedge funds are holding shares in EAPH
---
Company Description
Easton Pharmaceuticals
Easton Pharmaceuticals, Inc. engages in the design, development, and marketing of drugs, therapeutic, and cosmetic healthcare products. It owns wound-healing drug and topically delivered drugs to treat cancer and other therapeutic products. The company was founded by John K. Easton on February 4, 1997 and is headquartered in Toronto, Canada.
---
---